Back to search results

Community Partnership for Telehealth Solutions for Colorectal Cancer Screening

This study, called PRIME, is testing different ways to help people get screened for colorectal cancer (CRC). It focuses on the Latinx community. The study will use video text messages, mailed stool-test kits (FIT kits), and help with social needs to encourage screening. You might also receive reminders by text or phone for tests. We want to see if these methods increase the number of people who complete their CRC screening. You can join if you are between 45 and 64 years old, eligible for CRC screening, have been seen in the clinic recently, speak English or Spanish, have a cell phone, haven't had recent CRC screening, and live in certain neighborhoods. The study aims to enroll 6000 participants.

Study design
This is an interventional study, meaning participants will receive specific interventions. It is a non-randomized, two-arm stepped-wedge trial involving 6000 planned participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint measures colorectal cancer screening completion at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06542835

Community Partnership for Telehealth Solutions to Convey Information and Enhance Care

Recruiting
NAAges 45–64InterventionalScreening
University of Arizona
~6,000 participants
Updated 2026-03-30 on ClinicalTrials.gov
What's tested:Video text messageIn-clinic CRC screening promotionMailed FITSocial needs navigationReminders

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
CRC Screening Completion at the Individual Level
Measured over 6 months

Conditions

Colorectal Cancer

Explore related trials

Colorectal Carcinoma

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Anne Escaron, PhD · PRINCIPAL_INVESTIGATOR · AltaMed Health Services Corporation

Who to contact

Gloria Coronado, PhD
[email protected]
5039147100
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ages 45-64
Eligible for colorectal cancer (CRC) screening
Current patients (seen in the clinic in the last 6 months)
Primary speaker of English or Spanish
Cell phone listed in Electronic Health Record (EHR)
No recent history of CRC screening
Resides in one of the neighborhoods included in the main trial

Exclusion

Colorectal disease (e.g., ulcerative colitis or colectomy)
Personal history of colorectal cancer
End-stage or life-threatening diseases
Known to be under hospice care
Living in a skilled nursing facility
Patients who decline research participation will be removed from the patient contact list

What this trial measures

  • CRC Screening Completion at the Individual Level6 months

    Measure the completion rate of colorectal cancer (CRC) screening at the individual level within 6 months of receiving the intervention. This will compare the proportion of participants in the post-intervention group versus the pre-intervention group.